FTY720改善颅脑损伤大鼠神经功能的机制研究

doi:10.3877/cma.j.issn.1674-6880.2016.04.006

目的

探讨FTY720对颅脑损伤大鼠神经功能的影响及其相关机制研究。

方法

60只大鼠分成假手术组、模型组和治疗组，每组20只，采用改进的Feeney自由落体损伤装置建立大鼠颅脑损伤模型。治疗组大鼠按1 mg/kg剂量予FTY720腹腔注射，假手术组及模型组大鼠予以腹腔注射1 ml生理盐水。术后24 h，每组各取10只大鼠断头处死，分离海马组织，采用Western-blotting检测核因子κB表达水平，采用免疫组织化学染色法检测大鼠小胶质细胞OX-42表达水平。同时采用前肢放置试验评分、平衡实验评分及改良神经功能缺损程度评分进行神经功能评估。

结果

三组大鼠海马组织核因子κB蛋白表达水平（F=95.962，P<0.001）及小胶质细胞（F=108.853，P<0.001）比较，差异均有统计学意义。且模型组核因子κB蛋白及小胶质细胞OX-42表达水平较假手术组及治疗组明显增加（P均< 0.05）。同时，模型组大鼠术后7、14、21、28 d前肢放置试验评分[（7.0 ± 0.7）分vs.（6.3 ± 0.5）分，（5.9 ± 0.7）分vs.（5.0 ± 0.8）分，（4.9 ± 1.0）分vs.（3.8 ± 0.8）分，（3.7 ± 1.1）分vs.（2.3 ± 0.7）分；t=2.689、2.586、2.741、3.525，P=0.015、0.019、0.013、0.002]、平衡实验评分[（4.3 ± 0.7）分vs.（3.6 ± 0.7）分，（3.5 ± 1.1）分vs.（2.6 ± 0.7）分，（2.9 ± 0.9）分vs.（1.9 ± 0.7）分，（2.5 ± 0.7）分vs.（1.8 ± 0.6）分；t=2.278、2.212、2.762、2.333，P=0.035、0.040、0.013、0.031]及改良神经功能缺损程度评分[（10.1 ± 1.0）分vs.（8.7 ± 1.6）分，（8.8 ± 0.8）分vs.（7.5 ± 1.5）分，（7.3 ± 1.0）分vs.（5.6 ± 1.3）分，（5.7 ± 1.3）分vs.（4.1 ± 1.4）分；t=2.385、2.414、3.400、2.726，P=0.028、0.027、0.003、0.014]均明显高于治疗组。

结论

FTY720可显著改善颅脑损伤大鼠神经功能，其作用机制可能与FTY720的中枢炎症抑制作用有关。

关键词: 颅脑损伤, 大鼠, FTY720, 神经功能

Objective

To investigate the effect of FTY720 on neurological function in rats with traumatic brain injury and the related mechanism.

Methods

A total of 60 rats were randomly divided to the sham-operation group, model group and treatment group, 20 rats in each group. Modified Feeney free fall injury device was used to build rat craniocerebral injury model. Rats in the treatment group were administrated intraperitoneally with 1 mg/kg FTY720. Rats in the sham-operation group and model group were given 1 ml normal saline by intraperitoneal injection. After 24 hours, 10 rats in each group were sacrifice and their hippocampus tissues were used to determine the expression of nuclear factor-kappa B and microglial OX-42 by Western blotting and immunohistochemistry respectively. Additionally, the forelimb-placement test, balance test and modified neurological severity scores were used to assess the neurological function in each group.

Results

The expression of nuclear factor-kappa B (F=95.962, P<0.001) and microglial OX-42 (F=108.853, P<0.001) were all showed significant differences among the three groups, and were higher in the model group than those in the sham-operation group and treatment group (all P<0.05). Meanwhile, the forelimb-placement test [(7.0 ± 0.7) vs. (6.3 ± 0.5), (5.9 ± 0.7) vs. (5.0 ± 0.8), (4.9 ± 1.0) vs. (3.8 ± 0.8), (3.7 ± 1.1) vs. (2.3 ± 0.7); t=2.689, 2.586, 2.741, 3.525, P=0.015, 0.019, 0.013, 0.002], balance test [(4.3 ± 0.7) vs. (3.6 ± 0.7), (3.5 ± 1.1) vs. (2.6 ± 0.7), (2.9 ± 0.9) vs. (1.9 ± 0.7), (2.5 ± 0.7) vs. (1.8 ± 0.6); t=2.278, 2.212, 2.762, 2.333, P=0.035, 0.040, 0.013, 0.031] and modified neurological severity scores [(10.1 ± 1.0) vs. (8.7 ± 1.6), (8.8 ± 0.8) vs. (7.5 ± 1.5), (7.3 ± 1.0) vs. (5.6 ± 1.3), (5.7 ± 1.3) vs. (4.1 ± 1.4); t=2.385, 2.414, 3.400, 2.726, P=0.028, 0.027, 0.003, 0.014] on 7, 14, 21, 28 d after operation in the model group were higher as compared with the treatment group.

Conclusion

FTY720 could markedly improve the neurological function of rats with trauma brain injury and its mechanism might be related to the inhibition of FTY720 on central nervous system inflammation.

Key words: Craniocerebral trauma, Rat, FTY720, Neurological function

图1 FTY720对三组大鼠核因子κB蛋白表达的影响图。注：a图为各组大鼠核因子κB蛋白表达相对值的比较，与假手术组比较，^*P<0.05，与模型组比较，^#P<0.05；b图为Western-blotting检测下各组大鼠κB蛋白表达电泳图（n=10）

图2 FTY720对三组颅脑损伤大鼠海马组织小胶质细胞增生的影响图。注：a~c分别为假手术组、模型组及治疗组大鼠小胶质细胞OX-42表达情况（免疫组织化学染色× 20）

图3 FTY720对三组颅脑损伤大鼠海马组织OX-42染色阳性小胶质细胞的影响。注：与假手术组比较，^*P<0.05，与模型组比较，^#P<0.05（n=10）

表1 两组颅脑损伤大鼠不同时间点前肢放置实验评分的比较（分，±s）

组别	例数	1 d	3 d	7 d	14 d	21 d	28 d
模型组	10	8.5 ± 0.9	7.6 ± 0.8	7.0 ± 0.7	5.9 ± 0.7	4.9 ± 1.0	3.7 ± 1.1
治疗组	10	8.3 ± 0.7	7.3 ± 0.7	6.3 ± 0.5	5.0 ± 0.8	3.8 ± 0.8	2.3 ± 0.7
t值	?	0.583	0.878	2.689	2.586	2.741	3.525
P值	?	0.567	0.391	0.015	0.019	0.013	0.002

表1 两组颅脑损伤大鼠不同时间点前肢放置实验评分的比较（分，±s）

组别	例数	1 d	3 d	7 d	14 d	21 d	28 d
模型组	10	8.5 ± 0.9	7.6 ± 0.8	7.0 ± 0.7	5.9 ± 0.7	4.9 ± 1.0	3.7 ± 1.1
治疗组	10	8.3 ± 0.7	7.3 ± 0.7	6.3 ± 0.5	5.0 ± 0.8	3.8 ± 0.8	2.3 ± 0.7
t值	?	0.583	0.878	2.689	2.586	2.741	3.525
P值	?	0.567	0.391	0.015	0.019	0.013	0.002

表2 两组颅脑损伤大鼠不同时间点平衡实验评分的比较（分，±s）

组别	例数	1d	3d	7 d	14 d	21 d	28 d
模型组	10	5.4 ± 0.5	4.8 ± 0.6	4.3 ± 0.7	3.5 ± 1.1	2.9 ± 0.9	2.5 ± 0.7
治疗组	10	5.6 ± 0.7	4.3 ± 0.7	3.6 ± 0.7	2.6 ± 0.7	1.9 ± 0.7	1.8 ± 0.6
t值	?	0.728	1.709	2.278	2.212	2.762	2.333
P值	?	0.476	0.105	0.035	0.040	0.013	0.031

表2 两组颅脑损伤大鼠不同时间点平衡实验评分的比较（分，±s）

组别	例数	1d	3d	7 d	14 d	21 d	28 d
模型组	10	5.4 ± 0.5	4.8 ± 0.6	4.3 ± 0.7	3.5 ± 1.1	2.9 ± 0.9	2.5 ± 0.7
治疗组	10	5.6 ± 0.7	4.3 ± 0.7	3.6 ± 0.7	2.6 ± 0.7	1.9 ± 0.7	1.8 ± 0.6
t值	?	0.728	1.709	2.278	2.212	2.762	2.333
P值	?	0.476	0.105	0.035	0.040	0.013	0.031

表3 两组颅脑损伤大鼠不同时间点改良神经功能缺损程度评分的比较（分，±s）

组别	例数	1d	3d	7 d	14 d	21 d	28 d
模型组	10	13.8 ± 1.7	11.4 ± 1.8	10.1 ± 1.0	8.8 ± 0.8	7.3 ± 1.0	5.7 ± 1.3
治疗组	10	13.6 ± 1.7	10.9 ± 2.0	8.7 ± 1.6	7.5 ± 1.5	5.6 ± 1.3	4.1 ± 1.4
t值	?	0.263	0.578	2.385	2.414	3.400	2.726
P值	?	0.795	0.570	0.028	0.027	0.003	0.014

表3 两组颅脑损伤大鼠不同时间点改良神经功能缺损程度评分的比较（分，±s）

组别	例数	1d	3d	7 d	14 d	21 d	28 d
模型组	10	13.8 ± 1.7	11.4 ± 1.8	10.1 ± 1.0	8.8 ± 0.8	7.3 ± 1.0	5.7 ± 1.3
治疗组	10	13.6 ± 1.7	10.9 ± 2.0	8.7 ± 1.6	7.5 ± 1.5	5.6 ± 1.3	4.1 ± 1.4
t值	?	0.263	0.578	2.385	2.414	3.400	2.726
P值	?	0.795	0.570	0.028	0.027	0.003	0.014

[1]	de Rivero Vaccari JC, Brand FJ 3rd, Berti AF, et al. Mincle signaling in the innate immune response after traumatic brain injury[J]. J Neurotrauma, 2015, 32 (4): 228-236.
[2]	Kelso ML, Gendelman HE. Bridge between neuroimmunity and traumatic brain injury[J]. Curr Pharm Des, 2014, 20 (26): 4284-4298.
[3]	李肖亮，单爱军，杜波，等.急危重症患者继发性脑损伤救治中脑保护的研究进展[J/CD].中华危重症医学杂志：电子版，2011，4（1）：47-52.
[4]	Brune K, Patrignani P. New insights into the use of currently available non-steroidal anti-inflammatory drugs[J]. J Pain Res, 2015, 8 (1): 105-118.
[5]	Pitman MR, Woodcock JM, Lopez AF, et al. Molecular targets of FTY720 (fingolimod)[J]. Curr Mol Med, 2012, 12 (10): 1207-1219.
[6]	Patmanathan SN, Yap LF, Murray PG, et al. The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod[J]. J Cell Mol Med, 2015, 19 (10): 2329-2340.
[7]	Kawamata T, Dietrich WD, Schallert T, et al. Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction[J]. Proc Natl Acad Sci USA, 1997, 94 (15): 8179-8184.
[8]	Chen J, Li Y, Wang L, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats[J]. Stroke, 2001, 32 (4): 1005-1011.
[9]	Zhang L, Wang HD, Ji XJ, et al. FTY720 for cancer therapy (review)[J]. Oncol Rep, 2013, 30 (6): 2571-2578.
[10]	Estella-Hermoso de Mendoza A, Castello-Cros R, Imbuluzqueta E, et al. Lipid nanosystems enhance the bioavailability and the therapeutic efficacy of FTY720 in acute myeloid leukemia[J]. J Biomed Nanotechnol, 2015, 11 (4): 691-701.
[11]	Yoshida Y, Tsuji T, Watanabe S, et al. Efficacy of combination treatment with fingolimod (FTY720) plus pathogenic autoantigen in a glucose-6-phosphate isomerase peptide (GPI325-339)-induced arthritis mouse model[J]. Biol Pharm Bull, 2013, 36 (11): 1739-1746.
[12]	Hinson HE, Rowell S, Schreiber M. Clinical evidence of inflammation driving secondary brain injury: A systematic review[J]. J Trauma Acute Care Surg,2015, 78 (1): 184-191.
[13]	Abdul-Muneer PM, Schuetz H, Wang F, et al. Induction of oxidative and nitrosative damage leads to cerebrovascular inflammation in animal model of mild traumatic brain injury induced by primary blast[J]. Free Radic Biol Med, 2013 (60): 282-291.
[14]	Dong XQ, Du Q, Yu WH, et al. Anti-inflammatory effects of oxymatrine through inhibition of nuclear factor-kappa B and mitogen-activated protein kinase activation in lipopolysaccharide-induced BV2 microglia cells[J]. Iran J Pharm Res, 2013, 12 (1): 165-174.
[15]	Ghosh M, Garcia-Castillo D, Aguirre V, et al. Proinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microglia in vitro and following CNS injury[J]. Glia, 2012, 60 (12): 1839-1859.
[16]	Zhang W, Li B, Guo Y, et al. Rhamnetin attenuates cognitive deficit and inhibits hippocampal inflammatory response and oxidative stress in rats with traumatic brain injury[J]. Cent Eur J Immunol, 2015, 40 (1): 35-41.
[17]	Cui CM, Gao JL, Cui Y, et al. Chloroquine exerts neuroprotection following traumatic brain injury via suppression of inflammation and neuronal autophagic death[J]. Mol Med Rep, 2015, 12 (2): 2323-2328.
[18]	Janssen S, Schlegel C, Gudi V, et al. Effect of FTY720-phosphate on the expression of inflammation-associated molecules in astrocytes in vitro[J]. Mol Med Rep, 2015, 12 (4): 6171-6177.
[19]	Zhang Z, Zhang Z, Fauser U, et al. FTY720 attenuates accumulation of EMAP-Ⅱ+ and MHC-Ⅱ+ monocytes in early lesions of rat traumatic brain injury [J]. J Cell Mol Med, 2007, 11 (2): 307-314.
[20]	Rolland WB, Lekic T, Krafft PR, et al. Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage[J]. Exp Neurol, 2013 (1): 45-55.
[21]	Hasegawa Y, Suzuki H, Sozen T, et al. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats[J]. Stroke, 2010, 41 (2): 368-374.
[22]	Rolland WB 2nd, Manaenko A, Lekic T, et al. FTY720 is neuroprotective and improves functional outcomes after intracerebral hemorrhage in mice[J]. Acta Neurochir Suppl, 2011 (111): 213-217.

[1]	刘思锐, 赵辰阳, 张睿, 张一休, 杨萌. 多普勒超声对孕鼠子宫动脉不同节段血流动力学参数的评估[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(09): 877-883.
[2]	林琳, 田思萌, 于永华, 徐飞飞, 黄明莉. 干细胞及其外泌体治疗宫腔黏连的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 271-275.
[3]	杨文飞, 郝嘉文, 鲁梦远, 赵学刚, 李聪颖, 盖晨阳, 张晶, 张庆富. 高压电烧伤对大鼠心肌氧化应激的影响及N-乙酰半胱氨酸的干预作用[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(02): 106-112.
[4]	刘锦程, 王斌, 张雯, 张明周, 刘禹, 叶东樊, 黄赞胜, 邱凌霄, 卿斌, 王创业, 王南博, 王苹, 郭宇航, 周培花, 程秋霞, 徐智. 肺泡灌洗液RASSF1A及SHOX2甲基化联合径向超声特征对肺结节性质鉴别诊断的意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 505-511.
[5]	王守森, 傅世龙, 鲜亮, 林珑. 深入理解控制性减压技术对创伤性颅脑损伤术中脑膨出的预防机制与效果[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 257-262.
[6]	吴东阳, 林向丹, 石佐林, 赵玉龙, 王振, 文安国, 纪鑫, 李俊之, 赵明光. NF-L、NLRP3、S100B 蛋白在颅脑损伤严重程度及预后评估中的应用价值[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 279-285.
[7]	罗磊, 熊建平, 郑宏伟, 王嗣嵩, 柴祥, 吴青, 潘海鹏. 静脉留置针穿刺引流治疗颅骨修补术后硬膜外积液一例报道[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 315-317.
[8]	李刚, 潘晓帆, 田雪, 刘路路. CT灌注成像参数及血栓弹力图对急性前循环脑梗死早期神经功能恶化的预测价值分析[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(04): 226-232.
[9]	从长春, 王春琳, 武孝刚, 王金标, 章福彬, 孙磊, 王李. 重型颅脑损伤患者呼吸机相关性肺炎的危险因素及病原学分析[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(03): 151-157.
[10]	毛进鹏, 陶治鹤, 刘琦, 王勇, 周明安, 陈劲松, 田少斌. 保守治疗大量创伤性硬膜外血肿的体会（附10例报告）[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(03): 164-168.
[11]	辛强, 朱文豪, 何川, 李文臣, 陈勃, 王海峰. 神经胶质细胞来源的外泌体miRNAs对创伤性颅脑损伤后神经炎症的影响[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(03): 169-173.
[12]	鹿海龙, 朱玉辐, 贺雪凤, 蔡廷江, 王栋, 朱圣玲, 张恩刚, 王策. 创伤性颅脑损伤二次手术的危险因素分析及预警模型构建[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(02): 97-101.
[13]	胡志恒, 任洪波, 宋志远, 张运刚, 韩晓正. 血清sTIM-3及其配体Gal-9、CEACAM-1与创伤性颅脑损伤患者脑损伤程度及预后的关系[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(04): 201-207.
[14]	潘鑫, 黄晓云, 王超, 顾慧, 唐加波, 王鹏, 崔恒熙, 李政. 院前亚低温结合院内溶栓救治急性脑梗死的效果[J/OL]. 中华卫生应急电子杂志, 2024, 10(03): 145-148.
[15]	唐欣, 翟文海, 王润婷, 周胜宇, 靳航. 补体在缺血性卒中疾病中的研究进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 382-392.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Mechanism of FTY720 on neural function improvement of rats with traumatic brain injury

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Mechanism of FTY720 on neural function improvement of rats with traumatic brain injury